Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications

Triple-negative breast cancer (TNBC) accounts for ~15–20% of breast cancer (BC) and has a higher rate of early relapse and mortality compared to other subtypes. The Chemokine (C-C motif) ligand 5 (CCL5) and its signaling pathway have been linked to TNBC. We aimed to investigate the susceptibility an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Shan, Jingxuan, Chouchane, Aziz, Mokrab, Younes, Saad, Mohamad, Boujassoum, Salha, Sayaman, Rosalyn W., Ziv, Elad, Bouaouina, Noureddine, Remadi, Yasmine, Gabbouj, Sallouha, Roelands, Jessica, Ma, Xiaojing, Bedognetti, Davide, Chouchane, Lotfi
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6915105/
https://ncbi.nlm.nih.gov/pubmed/31921621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01328
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados